Titan Pharmaceuticals Inc (TTNP)

[Doctor Detroit]

Favorite Exchange From Conference Call

I seem to remember Kate Beebe saying "chomping at the bit" instead of "jumping at the bed," but you get the point...


John Vandermosten

Okay. And this point ProNeura has only been used with generic products. And I’m wondering, if there’s, or there might be any opportunities for any on patent products out there that might be helped with this technology, is that something that might be pursued?

Sunil Bhonsle

Absolutely, John, and it’s a very good question. And when you think of ProNeura and its basis for treatment basically providing a state-level of drug long-term typically something that is available only through IV therapy in hospitals that is somewhat restricted. And something like a ProNeura implant, which can provide that same benefit, while you are not restricted in a – in hospital setting is a major advantage.

And obviously, our first products have been in areas where there is already proven efficacy that provides a basis to show this technology works and we believe we’ve done that with Probuphine. We’re now moving into the next two products both of which have a lot of promise, but once again, they are both products based on compounds that already have shown to be effective.

Our next step really is to expand that both with drugs that are known to be effective and offering this technology as a basis for development of other products that are proprietary to other companies. And this includes products where potentially they see problem such as for as fast [ph] metabolism, which we can avoid by delivering a drug in this manner, that types possibly that are not easily delivered orally can be delivered in this manner.

So there are many opportunities. And our goal now and strategy starts expanding to include these opportunities by working with other companies who have proprietary compounds. Kate is looking forward to that very much.

Katherine Beebe

Yes, I’m jumping at the bed.